Drug Adherence In Hypertension And Cardiovascular Protection

July 12, 2018|
Drug Adherence In Hypertension And Cardiovascular Protection by Michel Burnier
Earn 1,065 plum® points
Buy Online
Ship to an address
Free shipping on orders over $35
Pick up in store
To see if pickup is available,
Buy In Store
Not sold in stores
Prices and offers may vary in store


This book provides a critical and comprehensive review of the methodologies available for measuring drug adherence in clinical practice, including those relying on emerging technologies. The authors discuss the risk factors of non-adherence and shed light on how to identify patients at risk of poor adherence. Drug therapies in chronic diseases rely heavily on the patient''s adherence, since drugs that are not taken are ineffective and leave the patient at high risk of developing clinical complications. Given the absence of new drugs for the treatment of hypertension, drug adherence is particularly important in these patients to improve blood pressure control. The book further investigates a new aspect, namely the importance of drug adherence in clinical trials and studies and draws attention to the limits of developing drugs without significant information on drug adherence. Several chapters are dedicated to the importance of adherence in specific forms of hypertension, such as resistant hypertension, dyslipidemia and hypertension associated with cardiovascular risk. As experts confronted with drug adherence in their daily practice, the authors analyse the real effectiveness of several interventions aimed at improving drug adherence and put particular emphasis on the importance of an interdisciplinary approach involving nurses and pharmacists. The volume also includes a careful analysis of the health and economic impact of poor adherence. The book is aimed at physicians, pharmacists, students and all health professionals dealing not only with hypertension or dyslipidemia, but also with chronic asymptomatic diseases such as diabetes, HIV or chronic respiratory diseases.

Michel Burnier is Professor of Medicine and head of the Nephrology and Hypertension Consultation division at the University Hospital of Lausanne, Switzerland. He trained in internal medicine and nephrology in Lausanne, Switzerland and at the University of Colorado Health Science Centre in Denver, Colorado. He is a member of the Scienti...
Title:Drug Adherence In Hypertension And Cardiovascular Protection
Product dimensions:314 pages, 9.25 X 6.1 X 0 in
Shipping dimensions:314 pages, 9.25 X 6.1 X 0 in
Published:July 12, 2018
Publisher:Springer Nature
Appropriate for ages:All ages
ISBN - 13:9783319765921

Look for similar items by category:

Recently Viewed